312
Participants
Start Date
July 31, 2002
Primary Completion Date
April 30, 2006
Study Completion Date
January 31, 2007
Daclizumub
anti-rejection drug
Tacrolimus
anti rejection drug
Cyclosporine
anti rejection drug
MMF
anti rejection drug
Baylor Regional Transplant Institute - Baylor University Medical Center, Dallas
Lead Sponsor
Collaborators (1)
Baylor Health Care System
OTHER
Emory University
OTHER
University of Southern California
OTHER
Mayo Clinic - Scottsdale/Phoenix, Arizona
UNKNOWN
New York Presbyterian Hospital
OTHER
Oregon Health and Science University
OTHER
New York University
OTHER
University of Cincinnati
OTHER
University of Alabama at Birmingham
OTHER
The University of Texas Health Science Center at San Antonio
OTHER
University of Chicago
OTHER
University of California, San Francisco
OTHER
Mayo Clinic - Rochester, Minnesota
UNKNOWN
Medical University of South Carolina
OTHER
University of Virginia
OTHER
Lahey Clinic
OTHER
University of Medicine and Dentistry of New Jersey
OTHER
Northwestern Memorial Hospital
OTHER
Baylor Research Institute
OTHER